webinar register page

Webinar banner
Rethinking “Early Catch” of Sepsis Using Game Changing Artificial Intelligence
Early identification and detection of sepsis has been proven to reduce the prevalence of sepsis and sepsis related adverse clinical outcomes such as septic shock and death. In this webinar, learn how new advanced predictive analytics technology is revolutionizing how clinicians identify at risk patients by providing patient specific artificial intelligence driven clinical decision support.

SPEAKERS:
Donny Johnson
CEO
Morley Medical, Inc.
*** Bio below.

Kiki Diorgu, MD, MBA
VP of Clinical Operations
Morley Medical, Inc.
*** Bio below.

Jul 22, 2020 02:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Donny Johnson
CEO @Morley Medical, Inc.
Mr. Johnson has over two decades of experience in the healthcare industry as a CEO, investor, and board member for several medical device and software companies. He leads teams of seasoned clinical and regulatory affairs specialists, scientists, researchers and industry veterans. He started with American Medical Research Institute, Inc. (“AMRI”) which was an oncology site management organization that managed oncology clinical research projects for 120 Oncologists in multiple states in the United States. Some of those clients included Novartis, Pfizer, Eli Lilly, Merck and Amgen. This later turned into Morley Research Consortium (full service CRO) which has helped early to mid-stage companies achieve successful clinical trial results in over 24 disciplines. His current role is as CEO of Morley Medical, an innovator in artificial intelligence, machine learning and clinical data services.
Kiki Diorgu, MD, MBA
VP of Clinical Operations @Morley Medical, Inc.
Dr. Diorgu is a medical professional with outstanding experience in clinical research, business development, medical device and regulatory affairs. Dr. Diorgu serves as the Vice President of Clinical Operations for Morley Medical. In this role, Dr. Diorgu has provided scientific and operational leadership in overseeing various medical device and medical drug projects in therapeutic areas including but not limited to infectious diseases, general surgery, neurology, cardiology, orthopedics and oncology.